Psychiatry’s Diagnostic Manual Under Drug Industry Influence
The undisclosed financial relationships between drug manufacturers and psychiatry’s leading "authorities" who determine what constitutes a “mental disorder” have been exposed.
No Evidence of Pandemic_US Center for Disease Control Changes Bird Flu Policy
The Tacoma Tribune reports that the head of the Center for Disease Control, Dr. Julie Gerberding, has reversed the agency’s bird flu policy, which viewed the threat from the worse-case scenario lens.
Scientific Misconduct: Cleaning Up the Paper Trail_SCIENCE
The APRIL 7, 2006 issue of SCIENCE Magazine contains one of the most important articles that tackles research fraud.
Poisoning Children_SF Chronicle
"Top Republicans — Senate Majority Leader Bill Frist, R-Tenn., and House Speaker Dennis Hastert, R-Ill– recently sold the future of our children to Big Pharma for a paltry $4 bucks a pop."
Disease Mongering_Conference / PLoS Special Issue
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
Company Knew of the Catastrophic Risk–so did the British Medicines Authority
"Risks of anaphylaxis applies to all studies at PAREXEL, with drugs at every stage of development, and the staff are well trained in anticipation of this (unlikely) possibility.
British Rethinking Rules After Ill-Fated Drug Trial_NYT
A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
London Drug Trial Catastrophe: Collapse of Science and Ethics
The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.
Red Light Districts in State Capitols_Peter Rost
The Pharmaceutical industry rakes in $500 billion globally–$230 billion in North America–57% of revenues is on marketing.
MHRA Releases Selective Documents–Where is Informed Consent Document?
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has released an interim report about the near fatal clinical trial of the monoclonal antibody, TGN1412, stating:
Pharma company Influence Medical Education Promotes OffLabel Use of Antipsychotic
Psychiatry’s professional practice paradigm has received a major blow.
CATIE study results Contradict Current Clinical Practice & Treatment Guidelines
Newly published results (phase II) from the CATIE schizophrenia treatment efficacy study sponsored by the National Institute of Mental Health comparing the most commonly used second generation drug treatments for schizophrenia and depression, is highly disturbing.